Back to search
A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430
NCT03800173
PHASE1INTERVENTIONAL
BioCryst Pharmaceuticals
32 participants
Started 2018-12-10 · Completed 2019-04-30
Status: Completed (as of 12-23-2025)
Conditions
Marburg Virus Disease
Interventions
Linked Papers (from SciSciNet-V2)
Total Papers0
Background
0Result
0Derived
0Unknown
0Brief Summary
This is a placebo-controlled, randomized, double-blind study to evaluate the pharmacokinetics of galidesivir following administration of single doses by IV infusion
No papers linked to this trial in SciSciNet
Visit ClinicalTrials.gov for more information about this study